IRIS
CLEMENTI, NICOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 654
NA - Nord America 541
AS - Asia 230
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 4
SA - Sud America 1
Totale 1.438
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 539
SE - Svezia 346
IT - Italia 145
SG - Singapore 110
CN - Cina 101
RU - Federazione Russa 89
FI - Finlandia 31
IE - Irlanda 16
DE - Germania 15
SA - Arabia Saudita 6
IN - India 5
AU - Australia 4
RO - Romania 4
CM - Camerun 3
IR - Iran 3
A1 - Anonimo 2
CA - Canada 2
CH - Svizzera 2
EU - Europa 2
FR - Francia 2
HK - Hong Kong 2
PL - Polonia 2
BR - Brasile 1
GB - Regno Unito 1
KR - Corea 1
NL - Olanda 1
PH - Filippine 1
PK - Pakistan 1
ZA - Sudafrica 1
Totale 1.438
Salva come PNG Salva come JPEG
Città #
Ashburn 105
Milan 87
Princeton 81
Shanghai 81
Lawrence 78
New York 64
Singapore 59
Moscow 41
Helsinki 28
Boardman 18
Dublin 16
Rome 9
Washington 9
Dallas 8
Los Angeles 8
Seattle 6
Guangzhou 5
Jeddah 5
Pune 5
Ancona 4
Santa Clara 4
Turin 4
Bologna 3
Busto Arsizio 3
Frankfurt Am Main 3
Lansing 3
Lappeenranta 3
Melbourne 3
Riccione 3
Ascoli Piceno 2
Beijing 2
Cernusco sul Naviglio 2
Como 2
Gatchina 2
Kunming 2
Las Vegas 2
South San Francisco 2
Tongling 2
Varese 2
Zurich 2
Andover 1
Bacoor 1
Bari 1
Bergamo 1
Bloemfontein 1
Borås 1
Central 1
Charlottesville 1
Dresano 1
Frankfurt am Main 1
Hamilton 1
Houston 1
Karachi 1
Kwai Chung 1
London 1
Lübeck 1
Naples 1
Napoli 1
Omsk 1
Palaia 1
Pisa 1
Portland 1
Riverside 1
Riyadh 1
Rockville 1
San Diego 1
San Francisco 1
Segrate 1
Shenzhen 1
St Petersburg 1
Sydney 1
São Paulo 1
Tehran 1
Volgograd 1
Yazd 1
Totale 803
Salva come PNG Salva come JPEG
Nome #
Cell-to-cell spread-blocking activity is extremely limited in the sera of HSV-1 and HSV-2 infected subjects 37
Antibody Titer Kinetics and SARS-CoV-2 Infections Six Months after Administration with the BNT162b2 Vaccine 34
Differential composition of vaginal microbiome, but not of seminal microbiome, is associated with successful intrauterine insemination in couples with idiopathic infertility: A prospective observational study 33
Cloning of the first human anti-JCPyV/VP1 neutralizing monoclonal antibody: Epitope definition and implications in risk stratification of patients under natalizumab therapy 30
Alternative methods of vaccine delivery: An overview of edible and intradermal vaccines 28
Unconventional CD147-dependent platelet activation elicited by SARS-CoV-2 in COVID-19 28
Entry inhibition of HSV-1 and -2 protects mice from viral lethal challenge 26
A Biologically-validated HCV E1E2 Heterodimer Structural Model 26
JC polyomavirus (JCV) and monoclonal antibodies: friends or potential foes? 25
A phage display vector optimized for the generation of human antibody combinatorial libraries and the molecular cloning of monoclonal antibody fragments 24
COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models 23
A non-VH1-69 heterosubtypic neutralizing human monoclonal antibody protects mice against H1N1 and H5N1 viruses 23
Detection of low-level HCV variants in DAA treated patients: comparison amongst three different NGS data analysis protocols 23
Combined Prophylactic and Therapeutic Use Maximizes Hydroxychloroquine Anti-SARS-CoV-2 Effects in vitro 23
Broad-range neutralizing anti-influenza A human monoclonal antibodies: new perspectives in therapy and prophylaxis. 22
Answer to Photo Quiz: Scolecobasidium sp 22
Broadly neutralizing anti-influenza human monoclonal antibodies and their possible role in predictive medicine 21
Microbiome Markers are Early Predictors of Acute GvHD in Allogeneic Hematopoietic Stem Cell Transplant recipients 21
Weak correlation between antibody titers and neutralizing activity in sera from SARS-CoV-2 infected subjects 21
Viral Respiratory Pathogens and Lung Injury 21
Novel therapeutic investigational strategies to treat severe and disseminated HSV infections suggested by a deeper understanding of in vitro virus entry processes 21
Nanopore ReCappable sequencing maps SARS-CoV-2 5' capping sites and provides new insights into the structure of sgRNAs 21
A Human Stem Cell-Derived Neurosensory–Epithelial Circuitry on a Chip to Model Herpes Simplex Virus Reactivation 20
A Human Monoclonal Antibody with Neutralizing Activity against Highly Divergent Influenza Subtypes 20
Interferon-β 1a inhibits SARS-CoV-2 in vitro when administered after virus infection 20
Broadly neutralizing human monoclonal antibodies: a novel resource against influenza viruses 20
The interferon landscape along the respiratory tract impacts the severity of COVID-19 20
Harmonization of six quantitative SARS-CoV-2 serological assays using sera of vaccinated subjects 20
A potential role for monoclonal antibodies in prophylactic and therapeutic treatment of influenza 19
Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein 19
Circulating SARS-CoV-2 variants in Italy, October 2020–March 2021 19
Case Report: Favorable outcome of allogeneic hematopoietic stem cell transplantation in SARSCoV2 positive recipient, risk-benefit balance between infection and leukemia 18
HUMAN MONOCLONAL ANTIBODY ENDOWED WITH ANTI-HSV-1 AND -2 ACTIVITY STRONGLY INHIBITS VIRUS REPLICATION 18
Adoptive T-cell therapy in the treatment of viral and opportunistic fungal infections 18
Fast inactivation of SARS-CoV-2 by UV-C and ozone exposure on different materials 18
Mechanisms of Hepatitis C Virus Escape from Vaccine-Relevant Neutralizing Antibodies 18
The efficacy of ultraviolet light-emitting technology against coronaviruses: a systematic review 18
Antigen-driven evolution of B lymphocytes in coronary atherosclerotic plaques 17
Neutralization Interfering Antibodies: a "Novel" Mechanism of Humoral Immune Mutiny and Viral Evasion? 17
Acute respiratory distress in a neutropenic febrile patient after hematopoietic cell transplantation 17
ANTI-HIV-1 RESPONSE ELICITED IN RABBITS BY ANTI-IDIOTYPE MONOCLONAL ANTIBODIES MIMICKING THE CD4-BINDING SITE ON GP120 17
Answer to February 2019 Photo Quiz: Neurological Symptoms in a 74-Year-Old Diabetic Woman Admitted to the Emergency Room 17
Proper Selection of In Vitro Cell Model Affects the Characterization of the Neutralizing Antibody Response against SARS-CoV-2 16
Influenza B-cells protective epitope characterization: a passkey for the rational design of new broad-range anti-influenza vaccines 16
Epitope mapping by epitope excision, hydrogen/deuterium exchange, and peptide-panning techniques combined with in silico analysis 16
IN VIVO PROTECTION CONFERRED BY HUMAN MONOCLONAL ANTIBODY DIRECTED AGAINST HSV-1 AND 2 16
Global and local envelope protein dynamics of hepatitis C virus determine broad antibody sensitivity 16
Characterization of a lineage c.36 sars-cov-2 isolate with reduced susceptibility to neutralization circulating in lombardy, italy 16
Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection 16
Anti-HIV-1 response elicited in rabbits by anti-idiotype monoclonal antibodies mimicking the CD4-binding site 15
Naringenin is a powerful inhibitor of SARS-CoV-2 infection in vitro 15
A case of psoriatic arthritis triggered by SARS-CoV-2 infection 15
Photo quiz: Neurological symptoms in a 74-year-old diabetic woman admitted to the emergency room 15
In Vitro Antimicrobial Activity of the Siderophore Cephalosporin Cefiderocol against Acinetobacter baumannii Strains Recovered from Clinical Samples 15
Molecular characterization of the human neutralizing response against hepatitis C virus and its role in the prediction of the infection outcome 15
Characterization of epitopes recognized by monoclonal antibodies: experimental approaches supported by freely accessible bioinformatic tools 14
Peptide-based vaccinology: experimental and computational approaches to target hypervariable viruses through the fine characterization of protective epitopes recognized by monoclonal antibodies and the identification of T-cell-activating peptides. 14
HCV E2 core structures and mAbs: something is still missing 14
Synergy evaluation of anti-Herpes Simplex Virus type 1 and 2 compounds acting on different steps of virus life cycle 14
Role and potential therapeutic use of antibodies against herpetic infections 14
Very high SARS-CoV-2 load at the emergency department presentation strongly predicts the risk of admission to the intensive care unit and death 14
Profiling Antibody Response Patterns in COVID-19: Spike S1-Reactive IgA Signature in the Evolution of SARS-CoV-2 Infection 14
Smallpox vaccination-elicited antibodies cross-neutralize 2022-Monkeypox virus Clade II 13
Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases 13
Impact of Remdesivir on SARS-CoV-2 Clearance in a Real-Life Setting: A Matched-Cohort Study 13
Enteric microbiome markers as early predictors of clinical outcome in allogeneic hematopoietic stem cell transplant (allo-HSCT): results of a prospective study in adult patients 13
Maturation signatures of conventional dendritic cell subtypes in COVID‐19 suggest direct viral sensing 13
Synergistic neutralization of HCV by two broadly neutralizing human monoclonal antibodies 13
Identification of a novel mutation involved in colistin resistance in Klebsiella pneumoniae through Next-Generation Sequencing (NGS) based approaches 12
Comparative Evaluation of the Bruker Biotyper and Vitek MS Matrix-Assisted Laser Desorption Ionization–Time Of Flight (MALDI-TOF) Mass Spectrometry Systems for Identification of Yeasts of Medical Importance 12
Phage display-based strategies for cloning and optimization of monoclonal antibodies directed against human pathogens 12
Lower nasopharyngeal viral load during the latest phase of COVID-19 pandemic in a Northern Italy University Hospital 12
Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020 12
Hepatitis C virus (HCV)-driven stimulation of subfamily-restricted natural IgM antibodies in mixed cryoglobulinemia 12
Recognition and inhibition of SARS-CoV-2 by humoral innate immunity pattern recognition molecules 11
Clinical characterization and whole genome sequence-based typing of two cases of endophthalmitis due to Listeria monocytogenes 11
Heterosubtypic protection conferred by the human monoclonal antibody PN-SIA28 against influenza A virus lethal infections in mice 11
IL-1 and IL-6 inhibition affects the neutralising activity of anti-SARS-CoV-2 antibodies in patients with COVID-19 11
Epidemiological and Clinical Features of SARS-CoV-2 Variants Circulating between April-December 2021 in Italy 10
SARS-CoV-2 detection in primary thyroid sarcoma: coincidence or interaction? 10
A spatial multi-scale fluorescence microscopy toolbox discloses entry checkpoints of SARS-CoV-2 variants in Vero E6 cells 10
Monoclonal antibodies isolated from human B cells neutralize a broad range of H1 subtype influenza A viruses including swine-origin Influenza virus (S-OIV) 10
Molecular Tracing of SARS-CoV-2 in Italy in the First Three Months of the Epidemic 10
Type III interferons disrupt the lung epithelial barrier upon viral recognition 10
Genomic epidemiology of the main SARS-CoV-2 variants in Italy between summer 2020 and winter 2021 9
Sites of vulnerability in HCV E1E2 identified by comprehensive functional screening 9
Hepatitis C virus (HCV) infection may elicit neutralizing antibodies targeting epitopes conserved in all viral genotypes 9
Title: Acute respiratory distress in a neutropenic febrile patient after Hematopoietic Cell Transplantation 9
Evaluation of a synergistic interactions of anti-E2/HCV monoclonal antibodies 9
Reply to: Hultström et al., Genetic determinants of mannose-binding lectin activity predispose to thromboembolic complications in critical COVID-19. Mannose-binding lectin genetics in COVID-19 8
Virus-induced preferential antibody gene-usage and its importance in humoral autoimmunity 8
Molecular cloning of the first human monoclonal antibodies neutralizing with high potency swine-origin influenza A pandemic virus (S-OIV) 8
Potential impact of a microarray-based nucleic acid assay for rapid detection of gram-negative bacteria and resistance markers in positive blood cultures 8
A case of breakthrough mpox infection in an individual non-responder to MVA-BN vaccination 8
Beauveria bassiana Keratitis: A Case Series and Review of Literature 7
ACOD1 deficiency offers protection in a mouse model of diet-induced obesity by maintaining a healthy gut microbiota 7
Unveiling the role of PUS7-mediated pseudouridylation in host protein interactions specific for the SARS-CoV-2 RNA genome 7
Chimeric antigen receptor (CAR)-redirected T cells: is there a place for them in infectious diseases? 7
Human Monoclonal Antibody able to nneutralize a broad range of H1 and H3 subtype influenza A viruses 7
SARS-CoV-2 infection despite high levels of vaccine-induced anti-Receptor-Binding-Domain antibodies: a study on 1110 health-care professionals from a northern Italian university hospital 7
Totale 1.604
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.540
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.540
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202012 0 0 0 0 0 0 9 0 0 0 0 3
2020/202128 5 1 0 3 6 0 3 4 0 6 0 0
2021/2022115 3 7 13 18 12 7 12 6 3 10 6 18
2022/2023643 191 151 74 8 7 82 43 45 24 2 11 5
2023/2024550 17 31 78 72 45 120 23 48 6 19 19 72
2024/2025205 178 27 0 0 0 0 0 0 0 0 0 0
Totale 1.643